↓ Skip to main content

Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)

Overview of attention for article published in Investigational New Drugs, June 1993
Altmetric Badge

Mentioned by

patent
2 patents

Citations

dimensions_citation
141 Dimensions

Readers on

mendeley
59 Mendeley
Title
Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)
Published in
Investigational New Drugs, June 1993
DOI 10.1007/bf00874153
Pubmed ID
Authors

Susanne Danhauser-Riedl, Edith Hausmann, Hans-D. Schick, Rita Bender, Hermann Dietzfelbinger, Johann Rastetter, Axel-R. Hanauske

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 2%
Unknown 58 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 15 25%
Student > Master 8 14%
Researcher 7 12%
Student > Bachelor 5 8%
Student > Doctoral Student 3 5%
Other 8 14%
Unknown 13 22%
Readers by discipline Count As %
Chemistry 11 19%
Medicine and Dentistry 8 14%
Pharmacology, Toxicology and Pharmaceutical Science 6 10%
Biochemistry, Genetics and Molecular Biology 4 7%
Materials Science 3 5%
Other 8 14%
Unknown 19 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 September 2013.
All research outputs
#7,658,506
of 23,314,015 outputs
Outputs from Investigational New Drugs
#333
of 1,188 outputs
Outputs of similar age
#6,056
of 20,935 outputs
Outputs of similar age from Investigational New Drugs
#1
of 1 outputs
Altmetric has tracked 23,314,015 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,188 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 20,935 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them